Access to palivizumab among children at high risk of respiratory syncytial virus complications in English hospitals. (2022)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1111/bcp.15069
PubMed Identifier: 34478568
Publication URI: http://europepmc.org/abstract/MED/34478568
Type: Journal Article/Review
Volume: 88
Parent Publication: British journal of clinical pharmacology
Issue: 3
ISSN: 0306-5251